Company

Sun Pharmaceutical

PrivateIndia

Sun Pharmaceutical is a privately held company, based in India. Leadership tracked by CEOInsider includes Dilip Shanghvi (CEO).

Latest on The Wire

See all →

IAA Leadership Awards 2026 Honour Dilip Shanghvi, Sidharth Malhotra and Industry Leaders
Aug 11 · via Press Trust of India
'In the next few years, many products will come out of India that will globally help patients'
Aug 10 · via manifest-media.in
NDTV Profit Business Leadership Awards: Sun Pharma's Dilip Sanghvi Wins 'Icon Of The Year' Award
Jul 26 · via NDTV Profit
A $12 Billion US Deal Pushes India’s Sun Pharma Into Big Leagues
May 4 · via Bloomberg.com

Leadership

Current

Dilip Shanghvi

CEO

The Wire

In the news

See in The Wire →

Dilip Shanghvi
Aug 11 · Sun Pharmaceutical
IAA Leadership Awards 2026 Honour Dilip Shanghvi, Sidharth Malhotra and Industry Leaders
via Press Trust of India ↗
Dilip Shanghvi
Aug 11 · Sun Pharmaceutical
IAA Leadership Awards 2026 Honour Dilip Shanghvi, Sidharth Malhotra and Industry Leaders
via TheWire.in ↗
Dilip Shanghvi
Aug 10 · Sun Pharmaceutical
'In the next few years, many products will come out of India that will globally help patients'
via manifest-media.in ↗
Dilip Shanghvi
Jul 26 · Sun Pharmaceutical
NDTV Profit Business Leadership Awards: Sun Pharma's Dilip Sanghvi Wins 'Icon Of The Year' Award
via NDTV Profit ↗
Dilip Shanghvi
May 4 · Sun Pharmaceutical
A $12 Billion US Deal Pushes India’s Sun Pharma Into Big Leagues
via Bloomberg.com ↗
Dilip Shanghvi
Apr 27 · Sun Pharmaceutical
Sun Pharma: How a small Kolkata trader became a global buyout artist
via The Economic Times ↗
Dilip Shanghvi
Apr 27 · Sun Pharmaceutical
Indian Pharma Billionaire Dilip Shanghvi Doubles Down On The U.S. With $11.8 Billion Acquisition
via Forbes ↗
Dilip Shanghvi
Apr 27 · Sun Pharmaceutical
What Dilip Shanghvi said on Sun Pharma's Organon Buy
via Rediff ↗
Dilip Shanghvi
Apr 26 · Sun Pharmaceutical
Sun Pharma shares jump 7% as India's largest drugmaker to buy U.S. firm Organon in $11.75 billion deal
via CNBC ↗
Dilip Shanghvi
Apr 26 · Sun Pharmaceutical
Sun Pharma puts seal on $11.75B Organon buyout
via firstwordpharma.com ↗
Dilip Shanghvi
Feb 13 · Sun Pharmaceutical
Focus on Building an Innovative Pipeline with Differentiated Assets: Dilip Shanghvi
via pharma.economictimes.indiatimes.com ↗
Dilip Shanghvi
Feb 9 · Sun Pharmaceutical
India Has A Limited Presence In Global Pharma: Dilip Shanghvi Of Sun Pharma
via LinkedIn ↗